Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 31, Issue 1, Pages 73
Publisher
Springer Nature
Online
2012-09-12
DOI
10.1186/1756-9966-31-73
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancer
- (2012) Hui Yi Xue et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Clusterin induces matrix metalloproteinase-9 expression via ERK1/2 and PI3K/Akt/NF-κB pathways in monocytes/macrophages
- (2011) Young-Jun Shim et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin
- (2011) Arti Shukla et al. Molecular Cancer
- Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel
- (2011) Mohamed Kamel Hassan et al. TUMOR BIOLOGY
- Clusterin Immunoexpression and its Clinical Significance in Patients with Non-Small Cell Lung Cancer
- (2010) Hecheng Li et al. LUNG
- Induction of Clusterin by AKT--Role in Cytoprotection against Docetaxel in Prostate Tumor Cells
- (2010) B. Zhong et al. MOLECULAR CANCER THERAPEUTICS
- Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays
- (2010) J. Bi et al. NEOPLASMA
- Current Status of Adjuvant Therapy for Pancreatic Cancer
- (2010) M. H. G. Katz et al. ONCOLOGIST
- Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway
- (2009) Teh-Ying Chou et al. CELLULAR SIGNALLING
- Doxycycline enhances the Ras-MAPK signaling and proliferation of mouse thymic epithelial cells
- (2009) Xun Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Serum Proteomic Approach for the Identification of Serum Biomarkers Contributed by Oral Squamous Cell Carcinoma and Host Tissue Microenvironment†
- (2009) Krikor Bijian et al. JOURNAL OF PROTEOME RESEARCH
- Clusterin as a Diagnostic and Prognostic Marker for Transitional Cell Carcinoma of the Bladder
- (2009) Sahar M. Hazzaa et al. PATHOLOGY & ONCOLOGY RESEARCH
- Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy
- (2008) Richard D. Sowery et al. BJU INTERNATIONAL
- Nuclear Factor- B p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
- (2008) X. Pan et al. CLINICAL CANCER RESEARCH
- Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex
- (2008) I. P. Trougakos et al. CLINICAL CANCER RESEARCH
- Clusterin Activates Survival through the Phosphatidylinositol 3-Kinase/Akt Pathway
- (2008) Hayet Ammar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clusterin, a novel modulator of TGF-β signaling, is involved in Smad2/3 stability
- (2007) Kwan-Bok Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now